Revelation Biosciences Warrant
REVBW
14 hedge funds and large institutions have $31.6K invested in Revelation Biosciences Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
17% more funds holding
Funds holding: 12 → 14 (+2)
5% more capital invested
Capital invested by funds: $30K → $31.6K (+$1.64K)
4.29% less ownership
Funds ownership: 35.4% → 31.11% (-4.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
+$3.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.29K |
| 3 |
CAC
Cowen and Company
New York
|
+$30 |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29 |
| 5 |
CS
Clear Street
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$30 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $10.6K | – | – | – |
|
|
PVI
2
Pine Valley Investments
Marlton,
New Jersey
| $4.22K | +$3.4K | +205,849 | +469% |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $4.17K | – | – | – |
|
4
Walleye Capital
New York
| $3.16K | – | – | – |
|
5
Walleye Trading
New York
| $1.77K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $1.69K | +$30 | +1,804 | +2% |
|
|
7
UBS Group
Zurich,
Switzerland
| $1.33K | +$1.29K | +78,000 | New |
|
|
AC
8
Ayrton Capital
Westport,
Connecticut
| $1.27K | – | – | – |
|
|
WAM
9
Wolverine Asset Management
Chicago,
Illinois
| $1.22K | -$30 | -1,805 | -2% |
|
10
Jane Street
New York
| $845 | – | – | – |
|
|
PFM
11
Privium Fund Management
Amsterdam,
Netherlands
| $744 | – | – | – |
|
|
EPM
12
Equitec Proprietary Markets
Chicago,
Illinois
| $338 | – | – | – |
|
|
13
Citadel Advisors
Miami,
Florida
| $279 | +$29 | +1,761 | +12% |
|
|
CS
14
Clear Street
New York
| $2 | +$2 | +100 | New |
|
REVBW Hedge Fund Activity: Q3 2023 in Review
14 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2023, worth a combined $31.6K — up 5.5% from $30K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new REVBW positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Pine Valley Investments, adding an estimated $3.4K. The largest seller was Wolverine Asset Management, cutting an estimated $30.
- 14 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2023, up from 12 in Q2 2023.
- Funds reported $31.6K of Revelation Biosciences Warrant stock for Q3 2023, up 5.5% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences Warrant positions in Q3 2023 and 0 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q3 2023 was Pine Valley Investments, an estimated $3.4K added.
- The largest Revelation Biosciences Warrant seller in Q3 2023 was Wolverine Asset Management, an estimated $30 sold.
Based on aggregated 13F filings for Q3 2023.